- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Journal of hepatology, 62.2015, 1, Supplement, S. S87-S99
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2015
- Creator
- DOI
-
10.1016/j.jhep.2015.02.006
- URN
-
urn:nbn:de:hebis:30:3-772053
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:52 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pawlotsky, Jean-Michel
- Feld, Jordan J.
- Zeuzem, Stefan
- Hoofnagle, Jay H.
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2015
Other Objects (12)
Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten
Overcoming the roadblocks in hepatitis C virus infection
IL28B single nucleotide polymorphisms in the treatment of hepatitis C
Viral hepatitis and its complications
Perspectives and challenges of interferon-free therapy for chronic hepatitis C
Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management
Ribavirin: current role in the optimal clinical management of chronic hepatitis C
Emerging therapies for the treatment of hepatitis C
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Concise review : interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection
Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten
Overcoming the roadblocks in hepatitis C virus infection
IL28B single nucleotide polymorphisms in the treatment of hepatitis C
Viral hepatitis and its complications
Perspectives and challenges of interferon-free therapy for chronic hepatitis C
Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management
Ribavirin: current role in the optimal clinical management of chronic hepatitis C
Emerging therapies for the treatment of hepatitis C
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Concise review : interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection
Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten
Overcoming the roadblocks in hepatitis C virus infection
IL28B single nucleotide polymorphisms in the treatment of hepatitis C
Viral hepatitis and its complications
Perspectives and challenges of interferon-free therapy for chronic hepatitis C
Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management
Ribavirin: current role in the optimal clinical management of chronic hepatitis C
Emerging therapies for the treatment of hepatitis C
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’